BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

GenesisCare extends Cancer Care Services

Elekta announced that GenesisCare, a leading global provider of integrated cancer care, has ordered 27 Flexitron® brachytherapy afterlo...

July 25, 2021 | News

Elekta Unity to advance precision radiation medicine

Presentation of 36 abstracts underscore the potential of Elekta Unity to advance precision radiation medicine Elekta (EKTA-B.ST) today announced the prese...

July 23, 2021 | News

Stimulating blood vessel formation with magnets

Magnetic field can be used to stimulate blood vessel growth, according to a study published in the journal Science and Technology of Advanced Materials. Th...

July 22, 2021 | News

Thermo Fisher Scientific Expands Hematology Oncology NGS Portfolio

Thermo Fisher Scientific today announced a new suite of Ion Torrent Oncomine immune repertoire assays designed to detect potentially malignant cl...

July 20, 2021 | News

Konyang University Hospital in South Korea relies on Molecular Health's MH Guide for personalized cancer medicine

It makes Konyang University Hospital the first facility in South Korea to use MH Guide. "Precision medicine in cancer care enables personalized treat...

July 16, 2021 | News

Hummingbird Bioscience and MD Anderson To Advance Innovative Immunotherapies

Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets to produce majo...

July 12, 2021 | News

MiRXES Secures US$77 Million To Accelerate Multi-Cancer Early Detection

MiRXES Pte Ltd, a biotechnology company focused on improving and saving lives with RNA-powered disease early detection tests, announced today it has ...

July 12, 2021 | News

Elekta optimizes treatment times for cancer patients

For the last several years, Elekta (EKTA-B.ST) has invested substantially in digitized service solutions to keep critical treatment machines up and running...

July 07, 2021 | News

Y-Biologics & Pierre Fabre enter into an agreement in the field of immuno-oncology

These antibodies have been functionally validated by the Pierre Fabre R&D teams for their specific properties on a pivotal immuno-oncology target actin...

July 06, 2021 | News

Roche to drive therapies to treat breast and lung cancer

According to Globocan, in 2020 the global burden of cancer increased to 19.3 million new cases and 10 million deaths[1]. Worldwide, the most common type of...

July 06, 2021 | News

QIAGEN Forms Strategic Alliance With Sysmex Corporation

Frankfurt Prime Standard:QIA) today announced a global strategic alliance with Japan’s Sysmex Corporation (Tokyo Stock Exchange, First Section [Ticke...

July 02, 2021 | News

I-Mab Announces Multiple Advancements of 4-1BB Bispecific Antibody Portfolio

First patient dosed in U.S. phase 1 clinical trial of TJ-CD4B/ABL111 in patients with advanced or metastatic solid tumors China sites to join the d...

July 02, 2021 | News

GenesisCare Expands their MR-guided Radiotherapy Reach

ViewRay, Inc. (NASDAQ: VRAY) today announced that GenesisCare has entered into a master purchase agreement for up to 14 MRIdian® MR-Guided Therapy Syst...

June 25, 2021 | News

Singapore to Introduce Fertility Preservation Services for Cancer Patients

Cancer treatments such as chemotherapy and radiation therapy can affect a woman's fertility by impacting the ovaries and other essential reproductive organ...

June 23, 2021 | News

Stay Connected